Related Experiment Video
Updated: Apr 28, 2026

Comprehensive Analysis of Drug Response using the FLICK Assay
Published on: June 6, 2025
A numerical method for analysis of in vitro time-dependent inhibition data. Part 2. Application to experimental data
Ken Korzekwa1, Donald Tweedie1, Upendra A Argikar1
1Department of Pharmaceutical Sciences, Temple University School of Pharmacy, Philadelphia, Pennsylvania (K.K., S.N.); Drug Metabolism and Pharmacokinetics, Boehringer Ingelheim, Ridgefield, Connecticut (D.T., A.W.-J.); and Analytical Sciences and Imaging (U.A.A.) and Metabolism and Pharmacokinetics (L.B., S.B.), Novartis Institutes for BioMedical Research Inc., Cambridge, Massachusetts.
A new numerical method effectively analyzes time-dependent inhibition (TDI) data for cytochrome P450 enzymes. This approach accurately models complex kinetics, improving understanding of drug-drug interactions.
Area of Science:
- Pharmacology
- Drug Metabolism
- Enzyme Kinetics
Background:
- Time-dependent inhibition (TDI) of cytochrome P450 enzymes is a key factor in drug-drug interactions.
- Current methods for characterizing TDI kinetics involve determining the rate of enzyme loss (kobs) at various inhibitor concentrations ([I]) and replotting to find kinetic parameters (KI and kinact).
Purpose of the Study:
- To apply a novel numerical method, developed in a companion study, to analyze experimental in vitro TDI data.
- To assess the method's ability to model complex and atypical TDI kinetic schemes.
Main Methods:
- Application of a new numerical method to five experimental TDI datasets involving CYP2B6, CYP2C8, and CYP3A4.
- Utilizing complex kinetic models, including quasi-irreversible inhibition, partial inhibition, and multiple-inhibitor binding models, where necessary.
Main Results:
- None of the analyzed datasets exhibited Michaelis-Menten-only kinetics.
- The numerical method successfully fitted complex models to the experimental data, revealing quasi-irreversible and partial inhibition kinetics.
- Three datasets required a multiple-inhibitor binding model for accurate parameterization.
Conclusions:
- The developed numerical method is generally applicable for analyzing in vitro TDI data, even with complex and atypical kinetic profiles.
- This approach enhances the mechanistic and clinical understanding of drug-drug interactions driven by cytochrome P450 enzyme inhibition.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10:28A Semi-High-Throughput Adaptation of the NADH-Coupled ATPase Assay for Screening Small Molecule Inhibitors
Published on: August 17, 2019